{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:12:12Z","timestamp":1761675132526,"version":"3.44.0"},"reference-count":169,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1995,11,1]],"date-time":"1995-11-01T00:00:00Z","timestamp":815184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1995,11,1]],"date-time":"1995-11-01T00:00:00Z","timestamp":815184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[1995,11]]},"DOI":"10.1016\/0002-8703(95)90214-7","type":"journal-article","created":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T09:46:44Z","timestamp":1094032004000},"page":"1094-1106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Newer developments in the management of atrial fibrillation"],"prefix":"10.1016","volume":"130","author":[{"given":"Stanley","family":"Nattel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0002-8703(95)90214-7_BIB1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00003495-199448030-00003","article-title":"The treatment of atrial fibrillation\u2014an evaluation of drug therapy, electrical modalities and therapeutic considerations","volume":"48","author":"Nattel","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/0002-8703(95)90214-7_BIB2","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/0735-1097(93)90765-S","article-title":"Atrial fibrillation: current understandings and research imperatives","volume":"22","author":"The National Heart, Lung, and Blood Institute Working Group on Atrial Fibrillation","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB3","series-title":"Atrial arrrhythmias: current concepts and management","first-page":"411","article-title":"Internal cardioversion for chronic atrial fibrillation","author":"Levy","year":"1990"},{"key":"10.1016\/0002-8703(95)90214-7_BIB4","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1001\/archinte.1991.00400100010002","article-title":"Atrial fibrillation and stroke","volume":"151","author":"Dalen","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB5","first-page":"721","article-title":"Atrial fibrillation and atrial flutter","volume":"12","author":"Geraets","year":"1993","journal-title":"Clin Pharm"},{"key":"10.1016\/0002-8703(95)90214-7_BIB6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/hrt.68.12.544","article-title":"Non-rheumatic atrial fibrillation: warfarin or aspirin for all?","volume":"68","author":"Nolan","year":"1992","journal-title":"Br Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB7","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1540-8159.1992.tb03143.x","article-title":"Atrial fibrillation: epidemiology and the risk and prevention of stroke","volume":"15","author":"Kalman","year":"1992","journal-title":"PACE Pacing Clin Electrophysiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB8","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/0735-1097(91)90559-R","article-title":"Antitachycardia devices: realities and promises","volume":"18","author":"Klein","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB9","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/01.CIR.85.5.1675","article-title":"Selective radiofrequency ablation of the slow pathway for the treatment of atrioventricular nodal reentrant tachycardia: evidence for involvement of perinodal myocardium within the reentrant circuit","volume":"85","author":"Kay","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/0002-8703(95)90214-7_BIB10","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1161\/01.CIR.85.6.2162","article-title":"Elimination of atrioventricular nodal reentrant tachycardia using discrete slow potentials to guide application of radiofrequency energy","volume":"85","author":"Haissaguerre","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/0002-8703(95)90214-7_BIB11","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJM199106063242301","article-title":"Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current","volume":"324","author":"Jackman","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1056\/NEJM199207303270504","article-title":"Treatment of supraventricular tachycardia due to atrioventricular nodal reentry by radiofrequency catheter ablation of slow-pathway conduction","volume":"327","author":"Jackman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2125.1991.tb03898.x","article-title":"The drug treatment of atrial fibrillation","volume":"32","author":"Channer","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB14","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJM199205073261906","article-title":"Management of atrial fibrillation","volume":"326","author":"Pritchett","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB15","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1378\/chest.101.4.1095","article-title":"Atrial fibrillation 1992: management strategies in flux","volume":"101","author":"Repique","year":"1992","journal-title":"Chest"},{"key":"10.1016\/0002-8703(95)90214-7_BIB16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0002-8703(91)90954-G","article-title":"Incidence and clinical significance of ST segment elevation after electrical cardioversion of atrial fibrillation and atrial flutter","volume":"121","author":"Van Gelder","year":"1991","journal-title":"Am Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB17","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/0735-1097(93)90593-P","article-title":"Changes in left and right atrial size after cardioversion of atrial fibrillation: role of mitral valve disease","volume":"22","author":"Gosselink","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0002-9149(93)90352-D","article-title":"Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease","volume":"72","author":"Van Gelder","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0002-9149(65)90005-6","article-title":"Cardiovascular response to exercise during atrial fibrillation and after conversion to sinus rhythm","volume":"16","author":"Benchimol","year":"1965","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB20","series-title":"Hemodynamic studies before and after conversion with quinidine","first-page":"499","article-title":"Auricular fibrillation","volume":"44","author":"Hansen","year":"1952"},{"key":"10.1016\/0002-8703(95)90214-7_BIB21","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0022-5223(19)33333-1","article-title":"Hemodynamic studies before and after cardioversion","volume":"48","author":"Kahn","year":"1964","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/0002-8703(95)90214-7_BIB22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1172\/JCI105381","article-title":"Hemodynamic effects after reversion from atrial fibrillation to sinus rhythm by precordial shock","volume":"45","author":"Killip","year":"1966","journal-title":"J Clin Invest"},{"key":"10.1016\/0002-8703(95)90214-7_BIB23","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/hrt.29.5.700","article-title":"Haemodynamic studies before and after electrical conversion of atrial fibrillation and flutter to sinus rhythm","volume":"29","author":"Resnekov","year":"1967","journal-title":"Br Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB24","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/01.CIR.38.6.1074","article-title":"Alterations in cardiac function immediately following electrical conversion of atrial fibrillation to normal sinus rhythm","volume":"38","author":"Shapiro","year":"1968","journal-title":"Circulation"},{"key":"10.1016\/0002-8703(95)90214-7_BIB25","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/hrt.59.5.572","article-title":"Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinus rhythm","volume":"59","author":"Lipkin","year":"1988","journal-title":"Br Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB26","first-page":"2576","article-title":"Atrial fibrillation: current therapeutic approaches","volume":"45","author":"Deantonio","year":"1992","journal-title":"Am Fam Physician"},{"issue":"suppl 6","key":"10.1016\/0002-8703(95)90214-7_BIB27","first-page":"S32","article-title":"Antiarrhythmic treatment of atrial arrhythmias","volume":"17","author":"Kulbertus","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB28","first-page":"903","article-title":"Factors determining success and energy requirements for cardioversion of atrial fibrillation","volume":"76","author":"Dalzell","year":"1990","journal-title":"Q J Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.0954-6820.1988.tb15764.x","article-title":"Chronic atrial fibrillation: long-term results of direct current conversion","volume":"223","author":"Lundstrom","year":"1988","journal-title":"Acta Med Scand"},{"key":"10.1016\/0002-8703(95)90214-7_BIB30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/archinte.1923.00110150044003","article-title":"A clinical report on the use of quinidine sulphate","volume":"31","author":"Viko","year":"1923","journal-title":"Arch Intern Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/BF00547059","article-title":"Cardioversion with flecainide in patients with atrial fibrillation of recent onset","volume":"27","author":"Goy","year":"1985","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB32","series-title":"Comparison of two regimens","first-page":"634","article-title":"Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate","volume":"9","author":"Crijns","year":"1988"},{"key":"10.1016\/0002-8703(95)90214-7_BIB33","doi-asserted-by":"crossref","first-page":"38D","DOI":"10.1016\/0002-9149(88)90503-6","article-title":"Restoration of sinus rhythm with flecainide in patients with atrial fibrillation","volume":"62","author":"Goy","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB34","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0002-9149(86)90022-6","article-title":"Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm","volume":"58","author":"Borgeat","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0002-9149(89)90253-1","article-title":"Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm","volume":"63","author":"Suttorp","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB36","first-page":"510","article-title":"Comparative evaluation of verapamil, flecainide and propafenone for the acute conversion of atrial fibrillation to sinus rhythm","volume":"17","author":"Kondili","year":"1990","journal-title":"Wiener Klin Wochenschr"},{"key":"10.1016\/0002-8703(95)90214-7_BIB37","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/0735-1097(90)90326-K","article-title":"The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm","volume":"16","author":"Suttorp","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0002-9149(89)90530-4","article-title":"Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset","volume":"64","author":"Bianconi","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/01.RES.71.2.271","article-title":"Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation","volume":"71","author":"Wang","year":"1992","journal-title":"Circ Res"},{"key":"10.1016\/0002-8703(95)90214-7_BIB40","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1161\/01.CIR.88.3.1030","article-title":"Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation: the importance of use-dependent effects on refractoriness","volume":"88","author":"Wang","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/0002-8703(95)90214-7_BIB41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9149(92)91392-H","article-title":"Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension","volume":"70","author":"Capucci","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB42","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/eurheartj\/14.8.1127","article-title":"Comparison of flecainide and procainamide in cardioversion of atrial fibrillation","volume":"14","author":"Madrid","year":"1993","journal-title":"Eur Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB43","first-page":"140","article-title":"Amiodarone versus quinidine for conversion of recent onset atrial fibrillation to sinus rhythm","volume":"49","author":"Pilati","year":"1991","journal-title":"Current Ther Res"},{"key":"10.1016\/0002-8703(95)90214-7_BIB44","doi-asserted-by":"crossref","first-page":"503","DOI":"10.7326\/0003-4819-106-4-503","article-title":"Digoxin for converting recent-onset atrial fibrillation to sinus rhythm: a randomized, double-blinded trial","volume":"106","author":"Falk","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB45","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/01.CIR.90.4.2032","article-title":"Class III antiarrhythmic drug action in experimental atrial fibrillation: differences in reverse use-dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide","volume":"90","author":"Wang","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/0002-8703(95)90214-7_BIB46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM196308152690701","article-title":"\u201cCardioversion\u201d of atrial fibrillation: a report on the treatment of 65 episodes in 50 patients","volume":"269","author":"Lown","year":"1963","journal-title":"N Engl J Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB47","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/0002-9149(88)90135-X","article-title":"The calamity of cardioversion of conscious patients","volume":"61","author":"Kowey","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB48","series-title":"Cardiology: fundamentals and practice","first-page":"767","article-title":"Supraventricular arrhythmias","author":"Wood","year":"1987"},{"key":"10.1016\/0002-8703(95)90214-7_BIB49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/hrt.32.1.26","article-title":"Systemic embolism in mitral valve disease","volume":"32","author":"Coulshed","year":"1970","journal-title":"Br Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB50","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0002-8703(51)90152-4","article-title":"Systemic arterial embolism in rheumatic heart disease","volume":"42","author":"Daley","year":"1951","journal-title":"Am Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB51","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/archinte.1951.03810100116012","article-title":"Studies in mitral stenosis. II. A correlation of postmortem findings with the clinical course of the disease in one hundred and one cases","volume":"88","author":"Graham","year":"1951","journal-title":"Arch Intern Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB52","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0002-9149(77)90064-9","article-title":"Influence of etiology of atrial fibrillation on incidence of systemic embolism","volume":"40","author":"Hinton","year":"1977","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archneur.1986.00520010065026","article-title":"Cardiogenic brain embolism","volume":"43","author":"Cerebral Embolism Task Force","year":"1986","journal-title":"Arch Neurol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB54","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0002-9149(69)90068-X","article-title":"The efficacy of anticoagulant therapy in preventing embolism related to DC cardioversion of atrial fibrillation","volume":"23","author":"Bjerkelund","year":"1969","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB55","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0735-1097(92)90530-Z","article-title":"Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter","volume":"19","author":"Arnold","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB56","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000110329","article-title":"Anticoagulation for atrial fibrillation and stroke prevention","volume":"12","author":"Boysen","year":"1993","journal-title":"Neuroepidemiology"},{"key":"10.1016\/0002-8703(95)90214-7_BIB57","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1056\/NEJM199303183281102","article-title":"Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi","volume":"328","author":"Manning","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB58","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9149(93)90889-K","article-title":"Impact of transesophageal echocardiography on the anticoagulation management of patients admitted with focal cerebral ischemia","volume":"72","author":"Hata","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB59","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0735-1097(94)90443-X","article-title":"Should all patients undergo transesophageal echocardiography before electrical cardioversion of atrial fibrillation?","volume":"23","author":"Grimm","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB60","first-page":"H104","article-title":"Atrial contractile performance after cessation of atrial fibrillation","volume":"264","author":"Leistad","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB61","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/01.CIR.82.3.792","article-title":"Atrial enlargement as a consequence of atrial fibrillation: a prospective echocardiographic study","volume":"82","author":"Sanfilippo","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/0002-8703(95)90214-7_BIB62","first-page":"I","article-title":"Atrial fibrillation begets atrial fibrillation","volume":"88","author":"Wijffels","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/0002-8703(95)90214-7_BIB63","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/0735-1097(93)90543-A","article-title":"Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography","volume":"22","author":"Grimm","year":"1993","journal-title":"J Am Coll Cardiol"},{"issue":"suppl A","key":"10.1016\/0002-8703(95)90214-7_BIB64","first-page":"28A","article-title":"Risk factors for atrial thrombus and stroke in 156 patients undergoing electrical cardioversion: a multicenter transesophageal echocardiographic study","volume":"21","author":"Black","year":"1993","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/0002-8703(95)90214-7_BIB65","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0735-1097(94)90412-X","article-title":"Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for \u201catrial stunning\u201d as a mechanism of thromboembolic complications","volume":"23","author":"Fatkin","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0002-8703(95)90045-4","article-title":"Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: an analysis of pooled trials","volume":"129","author":"Moreyra","year":"1995","journal-title":"Am Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB67","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/hrt.32.3.370","article-title":"Maintenance of sinus rhythm after DC reversion of atrial fibrillation","volume":"32","author":"Byrne-Quinn","year":"1970","journal-title":"Br Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB68","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/hrt.30.1.84","article-title":"Factors affecting cardioversion of atrial arrhythmias with special reference to quinidine","volume":"30","author":"Hall","year":"1968","journal-title":"Br Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB69","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/hrt.33.4.518","article-title":"Quinidine in maintenance of sinus rhythm after electroconversion of chronic atrial fibrillation: a controlled clinical study","volume":"33","author":"Hillestad","year":"1971","journal-title":"Br Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB70","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/hrt.37.5.486","article-title":"Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter: a multicenter study from Stockholm","volume":"37","author":"S\u00f6dermark","year":"1975","journal-title":"Br Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB71","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/oxfordjournals.eurheartj.a062498","article-title":"Disopyramide in the maintenance of sinus rhythm after electrocardioversion of atrial fibrillation: a placebo controlled one-year follow-up study","volume":"9","author":"Karlson","year":"1988","journal-title":"Eur Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB72","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0002-9149(89)90574-2","article-title":"Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter","volume":"64","author":"Van Gelder","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB73","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1161\/01.CIR.82.6.1932","article-title":"Sotalol versus quinidine for the maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation","volume":"82","author":"Juul-M\u00f6ller","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/0002-8703(95)90214-7_BIB74","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0735-1097(90)90649-A","article-title":"Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs","volume":"15","author":"Antman","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB75","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0002-9149(91)90828-9","article-title":"Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter","volume":"68","author":"Crijns","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB76","doi-asserted-by":"crossref","first-page":"2E","DOI":"10.1016\/0002-9149(87)90195-0","article-title":"Clinical types of proarrhythmic response to antiarrhythmic drugs","volume":"59","author":"Bigger","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB77","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/01.CIR.80.4.1063","article-title":"Mechanisms and risk factors for proarrhythmia with type Ia compared with Ic antiarrhythmic drug therapy","volume":"80","author":"Levine","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/0002-8703(95)90214-7_BIB78","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.CIR.82.4.1106","article-title":"Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta-analysis of randomized control trials","volume":"82","author":"Coplen","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/0002-8703(95)90214-7_BIB79","first-page":"431","article-title":"Amiodarone versus quinidine in the prophylaxis of atrial fibrillation","volume":"36","author":"Vitolo","year":"1981","journal-title":"Acta Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB80","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0002-8703(83)90009-1","article-title":"Efficacy of amiodarone for refractory supraventricular tachyarrhythmias","volume":"106","author":"Graboys","year":"1983","journal-title":"Am Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB81","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0735-1097(85)80232-1","article-title":"Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy","volume":"6","author":"Horowitz","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB82","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0002-9149(87)90307-9","article-title":"Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium","volume":"60","author":"Brodsky","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB83","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1001\/jama.1992.03480240051033","article-title":"Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter","volume":"267","author":"Gosselink","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/0002-8703(95)90214-7_BIB84","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0002-9149(86)90964-1","article-title":"Amiodarone for refractory atrial fibrillation","volume":"57","author":"Gold","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB85","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archinte.1987.00370080037009","article-title":"Amiodarone in the management of refractory atrial fibrillation","volume":"147","author":"Blevins","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB86","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1540-8167.1992.tb00972.x","article-title":"Amiodarone: pharmacology, clinical actions, and relationships between them","volume":"3","author":"Nattel","year":"1992","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB87","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/01.RES.73.6.1061","article-title":"Sustained depolarization-induced outward current in human atrial myocytes: evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents","volume":"73","author":"Wang","year":"1993","journal-title":"Circ Res"},{"key":"10.1016\/0002-8703(95)90214-7_BIB88","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1085\/jgp.96.1.195","article-title":"Two components of cardiac delayed rectifier K+ current","volume":"96","author":"Sanguinetti","year":"1990","journal-title":"J Gen Physiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB89","first-page":"H393","article-title":"Delayed rectifier outward K+ current is composed of two currents in guinea pig atrial cells","volume":"260","author":"Sanguinetti","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB90","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1096\/fasebj.5.3.2001794","article-title":"Molecular cloning and characterization of two voltage-gated K+ channel cDNAs from human ventricle","volume":"5","author":"Tamkun","year":"1991","journal-title":"FASEB J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB91","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/01.RES.73.1.210","article-title":"Identity of a novel delayed rectifier current from human heart with a cloned K+ channel current","volume":"73","author":"Fedida","year":"1993","journal-title":"Circ Res"},{"key":"10.1016\/0002-8703(95)90214-7_BIB92","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/01.RES.72.1.75","article-title":"Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent: specific block of rapidly activating delayed rectifier K+ current by dofetilide","volume":"72","author":"Jurkiewicz","year":"1993","journal-title":"Circ Res"},{"key":"10.1016\/0002-8703(95)90214-7_BIB93","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/cvr\/28.10.1540","article-title":"Rapid and slow components of delayed rectifier outward current in human atrial myocytes","volume":"28","author":"Wang","year":"1994","journal-title":"Cardiovasc Res"},{"key":"10.1016\/0002-8703(95)90214-7_BIB94","first-page":"211a","article-title":"Total synthesis, expression and functional assay of a gene encoding a human delayed rectifier potassium channel","volume":"57","author":"Swanson","year":"1990","journal-title":"Biophys J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB95","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0022-5223(19)37762-1","article-title":"Left atrial isolation: new technique for the treatment of supraventricular arrhythmias","volume":"80","author":"Williams","year":"1980","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"suppl 3","key":"10.1016\/0002-8703(95)90214-7_BIB96","first-page":"220","article-title":"Combined sinoatrial node atrio-ventricular isolation: a surgical alternative to His bundle ablation in patients with atrial fibrillation","volume":"72","author":"Guiraudon","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/0002-8703(95)90214-7_BIB97","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1001\/jama.1991.03470140088029","article-title":"Successful surgical treatment of atrial fibrillation: review and clinical update","volume":"266","author":"Cox","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/0002-8703(95)90214-7_BIB98","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/hrt.71.2.170","article-title":"Long-term results of the corridor operation for atrial fibrillation","volume":"71","author":"van Hemel","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB99","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1540-8167.1994.tb01146.x","article-title":"Successful catheter ablation of atrial fibrillation","volume":"5","author":"Ha\u00efssaguerre","year":"1994","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB100","first-page":"126A","article-title":"Transvenous low-energy cardioversion of short-duration atrial fibrillation in humans","author":"Murgatroyd","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB101","first-page":"125A","article-title":"Clinical efficacy and safety of atrial defibrillation using current nonthoracotomy endocardial lead configurations: a prospective randomized study","author":"Saksena","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB102","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0002-9149(90)90856-V","article-title":"Possible atrial proarrhythmic effects of class IC antiarrhythmic drugs","volume":"66","author":"Feld","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB103","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/0002-8703(71)90083-4","article-title":"Congestive heart failure following chronic tachycardia","volume":"81","author":"Coleman","year":"1971","journal-title":"Am Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB104","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/cs0620465","article-title":"The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog","volume":"62","author":"Riegger","year":"1982","journal-title":"Clin Sci"},{"key":"10.1016\/0002-8703(95)90214-7_BIB105","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1540-8159.1993.tb01714.x","article-title":"Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug-refractory atrial arrhythmias","volume":"16","author":"Hassam","year":"1993","journal-title":"PACE Pacing Clin Electrophysiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB106","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/0002-9149(93)90982-I","article-title":"Improvement in left ventricular function by ablation of atrioventricular nodal conduction in selected patients with lone atrial fibrillation","volume":"72","author":"Rodriguez","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB107","doi-asserted-by":"crossref","first-page":"71G","DOI":"10.1016\/0002-9149(92)91256-4","article-title":"Redefining the role of digoxin in the treatment of atrial fibrillation","volume":"69","author":"Sarter","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB108","series-title":"Cardiac therapy","first-page":"387","article-title":"The pharmacology of cardiac glycosides","author":"Hoffman","year":"1983"},{"key":"10.1016\/0002-8703(95)90214-7_BIB109","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0002-9149(75)90051-X","article-title":"Inefficacy of therapeutic serum levels of digoxin in controlling the ventricular rate in atrial fibrillation","volume":"35","author":"Goldman","year":"1975","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB110","first-page":"49","article-title":"The reaction to exercise of the heart affected by auricular fibrillation","volume":"11","author":"Blumgart","year":"1924","journal-title":"Heart"},{"key":"10.1016\/0002-8703(95)90214-7_BIB111","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/hrt.11.2.119","article-title":"The heart rate with exercise patients with auricular fibrillation","volume":"11","author":"Knox","year":"1949","journal-title":"Br Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB112","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1001\/jama.1941.02820200011003","article-title":"Use of digitalis to prevent exaggerated acceleration of the heart","volume":"116","author":"Modell","year":"1941","journal-title":"JAMA"},{"key":"10.1016\/0002-8703(95)90214-7_BIB113","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.0954-6820.1971.tb07437.x","article-title":"Digoxin dosage and ventricular rate at rest and exercise in patients with atrial fibrillation","volume":"190","author":"Redfors","year":"1971","journal-title":"Acta Med Scand"},{"key":"10.1016\/0002-8703(95)90214-7_BIB114","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1378\/chest.99.4.1038","article-title":"Failure of long-term digitalization to prevent rapid ventricular response in patients with paroxysmal atrial fibrillation","volume":"99","author":"Galun","year":"1991","journal-title":"Chest"},{"key":"10.1016\/0002-8703(95)90214-7_BIB115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/hrt.63.4.225","article-title":"Time of occurrence, duration and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin","volume":"63","author":"Rawles","year":"1990","journal-title":"Br Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB116","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1085\/jgp.85.5.621","article-title":"Interactions of organic calcium channel antagonists with calcium channels in single frog atrial cells","volume":"85","author":"Uehara","year":"1985","journal-title":"J Gen Physiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB117","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/01.CIR.74.5.1156","article-title":"Frequency-dependent effects of calcium antagonists on atrioventricular conduction and refractoriness: demonstration and characterization in anesthetized dogs","volume":"74","author":"Talajic","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/0002-8703(95)90214-7_BIB118","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/01.CIR.80.2.380","article-title":"Frequency-dependent effects of diltiazem on the atrioventricular node during experimental atrial fibrillation","volume":"80","author":"Talajic","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/0002-8703(95)90214-7_BIB119","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/01.CIR.86.3.870","article-title":"Rate-dependent effects of diltiazem on human atrioventricular nodal properties","volume":"86","author":"Talajic","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/0002-8703(95)90214-7_BIB120","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.CIR.73.2.316","article-title":"Efficacy of medium and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation","volume":"73","author":"Roth","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/0002-8703(95)90214-7_BIB121","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2125.1991.tb03898.x","article-title":"The drug treatment of atrial fibrillation","volume":"32","author":"Channer","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB122","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0002-8703(84)90592-1","article-title":"Effects of nadolol on the spontaneous and exercise-provoked heart rate in patients with chronic atrial fibrillation receiving stable doses of digoxin","volume":"108","author":"DiBianco","year":"1984","journal-title":"Am Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB123","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-8703(83)90246-6","article-title":"Verapamil improves exercise capacity in chronic atrial fibrillation: double-blind crossover study","volume":"105","author":"Lang","year":"1983","journal-title":"Am Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB124","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1378\/chest.83.3.491","article-title":"Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation","volume":"83","author":"Lang","year":"1983","journal-title":"Chest"},{"key":"10.1016\/0002-8703(95)90214-7_BIB125","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0735-1097(90)90461-W","article-title":"Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil","volume":"16","author":"Lundstrom","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB126","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1378\/chest.93.1.20","article-title":"Diltiazem and exercise performance in patients with chronic atrial fibrillation","volume":"93","author":"Atwood","year":"1988","journal-title":"Chest"},{"issue":"11","key":"10.1016\/0002-8703(95)90214-7_BIB127","first-page":"639","article-title":"Treatment of supraventricular tachyarrhythmias with intravenous calcium-channel blockers","volume":"56","author":"Pharand","year":"1992","journal-title":"Conn Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB128","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0735-1097(91)90743-S","article-title":"A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study","volume":"18","author":"Ellenbogen","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB129","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0002-9149(89)90141-0","article-title":"Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter","volume":"63","author":"Platia","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-199346040-00007","article-title":"Sotalol: an updated review of its properties and therapeutic use in cardiac arrhythmias","volume":"46","author":"Fitton","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/0002-8703(95)90214-7_BIB131","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2165\/00003495-198734030-00002","article-title":"Sotalol: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use","volume":"34","author":"Singh","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/0002-8703(95)90214-7_BIB132","first-page":"88A","article-title":"Effects of class III drugs on AV node functional properties","author":"Nayebpour","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB133","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/00003495-198836020-00001","article-title":"Recent advances in understanding the pharmacology of amiodarone","volume":"36","author":"Nattel","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/0002-8703(95)90214-7_BIB134","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/01.RES.69.2.519","article-title":"Suppression of time-dependent outward current in guinea pig ventricular myocytes: actions of quinidine and amiodarone","volume":"69","author":"Balser","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/0002-8703(95)90214-7_BIB135","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00005344-198903000-00013","article-title":"Attenuation of Class 3 and sinus node effects of amiodarone by experimental hyperthyroidism","volume":"13","author":"Talajic","year":"1989","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB136","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.1982.03330070039027","article-title":"Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias","volume":"248","author":"Scheinman","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/0002-8703(95)90214-7_BIB137","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1540-8159.1991.tb04044.x","article-title":"Advances in applications of radiofrequency current to catheter ablation therapy","volume":"14","author":"Huang","year":"1991","journal-title":"PACE Pacing Clin Electrophysiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB138","first-page":"I","article-title":"Dramatic reduction in ventricular response during atrial fibrillation by ablating the atrioventricular nodal slow pathway: electrophysiologic and clinical implications","volume":"88","author":"Blanck","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/0002-8703(95)90214-7_BIB139","first-page":"I","article-title":"Radiofrequency catheter modification of the AV node for control of rapid ventricular response to atrial fibrillation","volume":"88","author":"Feld","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/0002-8703(95)90214-7_BIB140","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1056\/NEJM199410063311404","article-title":"Radiofrequency catheter modification of atrioventricular conduction to control the ventricular rate during atrial fibrillation","volume":"331","author":"Williamson","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB141","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM198204293061703","article-title":"Epidemiological features of chronic atrial fibrillation: the Framingham Study","volume":"306","author":"Kannel","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB142","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1161\/01.STR.14.5.664","article-title":"Duration of atrial fibrillation and imminence of stroke: the Framingham Study","volume":"14","author":"Wolf","year":"1983","journal-title":"Stroke"},{"key":"10.1016\/0002-8703(95)90214-7_BIB143","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.28.10.973","article-title":"Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham Study","volume":"28","author":"Wolf","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/0002-8703(95)90214-7_BIB144","doi-asserted-by":"crossref","first-page":"118S","DOI":"10.1378\/chest.95.2_Supplement.118S","article-title":"Antithrombotic therapy in atrial fibrillation","volume":"95","author":"Dunn","year":"1989","journal-title":"Chest"},{"key":"10.1016\/0002-8703(95)90214-7_BIB145","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/ageing\/21.5.374","article-title":"Review: atrial fibrillation and stroke prevention","volume":"21","author":"O'Connell","year":"1992","journal-title":"Age Ageing"},{"key":"10.1016\/0002-8703(95)90214-7_BIB146","series-title":"That is no longer the question","first-page":"461","article-title":"To anticoagulate or not to anticoagulate?","author":"Silverman","year":"1993"},{"key":"10.1016\/0002-8703(95)90214-7_BIB147","doi-asserted-by":"crossref","first-page":"6","DOI":"10.7326\/0003-4819-116-1-6","article-title":"Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk","volume":"116","author":"Stroke Prevention in Atrial Fibrillation Investigators","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB148","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0002-8703(92)90933-M","article-title":"Risk factors for systemic embolism in patients with paroxysmal atrial fibrillation","volume":"124","author":"Corbal\u00e1n","year":"1992","journal-title":"Am Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB149","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0002-9343(91)90008-L","article-title":"Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study","volume":"91","author":"Moulton","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB150","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM198709103171104","article-title":"The natural history of lone atrial fibrillation: a population-based study over three decades","volume":"317","author":"Kopecky","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB151","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1056\/NEJM199011293232201","article-title":"The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation","volume":"323","author":"Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB152","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(91)90585-W","article-title":"Canadian Atrial Fibrillation Anticoagulation (CAFA) Study","volume":"18","author":"Connolly","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/0002-8703(95)90214-7_BIB153","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study","volume":"1","author":"Peterson","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/0002-8703(95)90214-7_BIB154","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","article-title":"Stroke Prevention in Atrial Fibrillation Study: final results","volume":"84","author":"Stroke Prevention in Atrial Fibrillation Investigators","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/0002-8703(95)90214-7_BIB155","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","article-title":"Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation","volume":"327","author":"Veterans' Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB156","first-page":"687","article-title":"Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in atrial fibrillation II study","volume":"343","author":"Stroke Prevention in Atrial Fibrillation Investigators","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/0002-8703(95)90214-7_BIB157","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0736-4679(90)90380-E","article-title":"Propafenone versus amiodarone in field treatment of primary tachydysrhythmias","volume":"8","author":"Bertini","year":"1990","journal-title":"J Emerg Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB158","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/oxfordjournals.eurheartj.a061163","article-title":"Controlled trial of a long-acting quinidine for maintenance of sinus rhythm after conversion of sustained atrial fibrillation","volume":"2","author":"Boissel","year":"1981","journal-title":"Eur Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB159","first-page":"22","article-title":"Verapamil and quinidine in maintaining sinus rhythm after electroconversion of atrial fibrillation","volume":"27","author":"Edhag","year":"1982","journal-title":"Opusc Med"},{"key":"10.1016\/0002-8703(95)90214-7_BIB160","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/hrt.32.4.462","article-title":"Long-term follow-up of direct current cardioversion after cardiac surgery with special reference to quinidine","volume":"32","author":"Gunning","year":"1970","journal-title":"Br Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB161","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/hrt.32.1.57","article-title":"Value of quinidine in maintenance of sinus rhythm after electric cardioversion of atrial fibrillation","volume":"32","author":"H\u00e4rtel","year":"1970","journal-title":"Br Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB162","first-page":"367","article-title":"The efficacy of quinidine and disopyramide in the maintenance of sinus rhythm after electroconversion from atrial fibrillation: a double-blind study comparing quinidine, disopyramide and placebo","volume":"65","author":"Lloyd","year":"1984","journal-title":"S Afr Med J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB163","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/hrt.30.1.91","article-title":"Long term results of DC reversion of atrial fibrillation","volume":"30","author":"Radford","year":"1968","journal-title":"Br Heart J"},{"issue":"suppl 645","key":"10.1016\/0002-8703(95)90214-7_BIB164","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.0954-6820.1981.tb02597.x","article-title":"Comparative efficiency of quinidine and verapamil in the maintenance of sinus rhythm after DC conversion of atrial fibrillation: a controlled clinical trial","author":"Rasmussen","year":"1981","journal-title":"Acta Med Scand"},{"key":"10.1016\/0002-8703(95)90214-7_BIB165","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/cpt1974156551","article-title":"Disopyramide in the prevention of atrial fibrillation after electroconversion","volume":"15","author":"H\u00e4rtel","year":"1974","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/0002-8703(95)90214-7_BIB166","first-page":"II","article-title":"Flecainide in the prevention of atrial fibrillation after cardioversion: comparison with quinidine","volume":"84","author":"Touboul","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/0002-8703(95)90214-7_BIB167","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0735-1097(88)90468-8","article-title":"Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter","volume":"12","author":"Antman","year":"1988","journal-title":"J Am Coll Cardiol"},{"issue":"suppl 1","key":"10.1016\/0002-8703(95)90214-7_BIB168","first-page":"52","article-title":"Flecainide versus disopyramide in maintaining sinus rhythm following conversion of chronic atrial fibrillation","volume":"9","author":"Rasmussen","year":"1988","journal-title":"Eur Heart J"},{"key":"10.1016\/0002-8703(95)90214-7_BIB169","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0002-9149(93)90511-A","article-title":"Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation","volume":"71","author":"Reimold","year":"1993","journal-title":"Am J Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0002870395902147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0002870395902147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T05:39:48Z","timestamp":1756877988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0002870395902147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,11]]},"references-count":169,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1995,11]]}},"alternative-id":["0002870395902147"],"URL":"https:\/\/doi.org\/10.1016\/0002-8703(95)90214-7","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[1995,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Newer developments in the management of atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/0002-8703(95)90214-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1995 Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}